We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • Topics
  • CME
  • Special Reports
  • Slideshows
  • Quizzes
  • Blogs
  • Conferences
  • Classifieds
  • Archives

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • Topics
  • CME
  • Special Reports
  • Slideshows
  • Quizzes
  • Blogs
  • Conferences
  • Classifieds
  • Archives

SUBSCRIBE: eNewsletter

Substance Use Disorder

©Shutterstock

Online Communities for Drug Withdrawal: What Can We Learn?

  • Josef Witt-Doerring, MBBS
  • Daryl Shorter, MD
  • Thomas Kosten, MD
Apr 18, 2018

In this age of chat rooms and social media, an ever-growing number of psychiatric patients use the internet to find their treatment community online.

©ESBProfessional/Shutterstock

Opioid Overdoses and Naloxone: What Everyone Needs to Know

  • Saeed Ahmed, MD
  • Cornel Stanciu, MD
  • Thomas M. Penders, MD, MS
Feb 2, 2018

More than 6 out of 10 deaths involve prescribed opioids. The authors address guidelines for who should (and who should not) receive a naloxone prescription.

New Diagnostic Codes for Substance Use Disorders and Avoidant/Restrictive Food Intake Disorder

  • Michael B. First, MD
Oct 12, 2017

Several updates to ICD-10-CM affect the diagnostic codes used by mental health practitioners. One important update involves the codes for substance use disorders. Details here.

Mini Quiz: Alcohol and Sleep

  • Kristen Schmidt, MD
  • Bhanu Prakash Kolla, MD, MRCPsych
Display date: 
Sep 28, 2017

Which sleep parameters are increased in alcohol use disorders? Take the quiz and learn more.

Q&A: Clinical Challenges in Substance Use Disorders

  • Coreen Domingo, DrPH, MPH
  • Thomas R. Kosten, MD
Sep 17, 2017

What's the optimal strategy toward recovery from opioid use disorder? Which treatment for nicotine addiction has the most favorable adverse-effect profile?

8 Distinguishing Features of Primary Psychosis Versus Cannabis-Induced Psychosis

  • Ruby S. Grewal, MD
  • Tony P. George, MD, FRCPC
Aug 4, 2017

The authors compare the clinical features of idiopathic psychosis (eg, schizophrenia) with cannabis-induced psychosis.

i3alda

Treatment for Cannabis Use Disorders: A Case Report

  • Christina Brezing, MD
  • Frances Levin, MD
Aug 2, 2017

It is vital that psychiatrists are able to identify and characterize cannabis use disorders; provide education; and offer effective, evidence-based treatments. This article provides a brief overview of each of these topics.

ADHD and Substance Use: Current Evidence and Treatment Considerations

  • Chardée A. Galán, MS
  • Kathryn L. Humphreys, PhD, EdM
Aug 2, 2017

Because comorbid substance abuse is the rule rather than the exception in individuals with ADHD, accurate diagnosis, prognosis, and management of ADHD is challenging even for the most skilled practitioners.

GianlucaRasile/Shutterstock

E-Cigarettes, Vaping, and Other Electronic Nicotine Products: Harm Reduction Pathways or New Avenues for Addiction?

  • Smita Das, MD, PhD, MPH
  • Judith J. Prochaska, PhD, MPH
Aug 2, 2017

This article summarizes data on e-cigarettes, provides recommendations and resources to learn more, and emphasizes the evidence for treating tobacco (traditional cigarettes) addiction in people with mental illness.

New Insights on Substance Use Disorders

  • Thomas R. Kosten, MD
Jul 28, 2017

A clinical collection on addiction treatment, ADHD and SUDs, important drug indications, vaping, cannabis use, benzodiazepines, the perils of self-medicating and other topics relevant to practicing psychiatrists.

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
ADHD
Schizophrenia
Bipolar Disorder
Geriatric Psychiatry
Major Depressive Disorder
Smart IOP – A New Kind of Intensive Outpatient Program
Three Things Mental Health Professionals Need to Know About Telemedicine – TODAY!
How Telemedicine Can Transform Patient Engagement

Current Issue

Psychiatric Times Vol 35 No 3
Mar 12, 2018 Vol 32 No 3
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • Google+
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.